| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |